ABSORB GT1
Device
Abbott Laboratories
Total Payments
$473,392
Transactions
309
Doctors
74
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $949.59 | 17 | 17 |
| 2023 | $8,981 | 7 | 6 |
| 2022 | $463,461 | 285 | 51 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $449,919 | 216 | 95.0% |
| Travel and Lodging | $8,795 | 2 | 1.9% |
| Consulting Fee | $8,500 | 11 | 1.8% |
| Food and Beverage | $6,178 | 80 | 1.3% |
Payments by Type
Research
$449,919
216 transactions
General
$23,474
93 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions | Abbott Laboratories | $449,919 | 0 |
Top Doctors Receiving Payments for ABSORB GT1 — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Glendale, CA | $140.75 | 1 |
| , MD | Cardiovascular Disease | Scottsdale, AZ | $137.61 | 1 |
| , MD | Cardiovascular Disease | Saint Louis, MO | $135.83 | 1 |
| , MD, PHD | Cardiovascular Disease | Chestnut Hill, MA | $128.39 | 1 |
| , D.O | Cardiovascular Disease | Ann Arbor, MI | $121.90 | 1 |
| , M.D | Internal Medicine | Oklahoma City, OK | $120.32 | 1 |
| , DO | Anesthesiology | Travis Afb, CA | $119.22 | 1 |
| Padmanabhan Krishnan | Pulmonary Disease | Brooklyn, NY | $116.75 | 1 |
| , M.D | Interventional Cardiology | Brighton, MA | $115.57 | 1 |
| , MD | Interventional Cardiology | Sanford, NC | $107.23 | 1 |
| , MD | Vascular Surgery | San Diego, CA | $89.29 | 1 |
| , MD | Internal Medicine | Boynton Beach, FL | $79.39 | 1 |
| , MD | Vascular Surgery | Aurora, CO | $75.79 | 1 |
| , MD | Vascular Surgery | Aurora, CO | $75.79 | 1 |
| , D.O | Anesthesiology | Lancaster, PA | $71.60 | 3 |
| , MD | Vascular Surgery | Tucson, AZ | $69.66 | 1 |
| , M.D | Cardiovascular Disease | Saint Louis, MO | $69.56 | 1 |
| , DO | Clinical Cardiac Electrophysiology | Louisville, KY | $52.24 | 1 |
| , M.D | Surgery | Portland, ME | $49.86 | 1 |
| , MD | Family Medicine | Dallas, TX | $49.86 | 1 |
| , D.O | Physical Medicine & Rehabilitation | Michigan City, IN | $49.86 | 1 |
| , M.D | Vascular Surgery | Minneapolis, MN | $49.85 | 1 |
| , M.D | Surgery | Tacoma, WA | $49.85 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | New York, NY | $49.85 | 1 |
| , M.D | Surgery | Palo Alto, CA | $49.85 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $473,392
Product Information
- Type Device
- Total Payments $473,392
- Total Doctors 74
- Transactions 309
About ABSORB GT1
ABSORB GT1 is a device associated with $473,392 in payments to 74 healthcare providers, recorded across 309 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $949.59 was paid across 17 transactions to 17 doctors.
The most common payment nature for ABSORB GT1 is "Unspecified" ($449,919, 95.0% of total).
ABSORB GT1 is associated with 1 research study, including "A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions" ($449,919).